Welcome to our dedicated page for Arcbest SEC filings (Ticker: ARCB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ArcBest Corporation (ARCB) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. ArcBest’s filings include current reports on Form 8-K, annual and quarterly reports, and exhibits that describe its financial condition, operating performance, governance changes and key agreements.
For investors analyzing ARCB, Form 8-K filings are especially important. Recent 8-Ks have covered topics such as unaudited quarterly results, including detailed segment data for the Asset-Based and Asset-Light businesses, non-GAAP reconciliations, and slides used in earnings conference calls. Other 8-Ks describe board and executive changes, director appointments, leadership succession, quarterly cash dividends, share repurchase authorizations and amendments to the company’s revolving credit facility.
ArcBest’s credit facility disclosures, for example, outline the terms of its Fifth Amended and Restated Credit Agreement, including the maximum credit amount, swing line and letter of credit sub-facilities, maturity date, pricing based on leverage ratios and key covenants. These filings also describe cross-guarantees by ArcBest and its material domestic subsidiaries, as well as customary events of default and financial ratio requirements.
On this page, Stock Titan surfaces ARCB filings as they are posted to EDGAR and enhances them with AI-powered summaries. AI explanations help clarify complex sections of lengthy reports, highlight segment-level trends, and point out items such as non-GAAP adjustments, debt terms and capital allocation actions. Users can quickly locate quarterly reports, annual reports, and current reports, and review how ArcBest communicates its operating performance, risk factors and strategic decisions through its official SEC documents.
ArcBest Corp. director Chris T. Sultemeier received a stock grant. On May 5, 2026, he was awarded 1,350 shares of ArcBest common stock at a stated price of $0.00 per share, indicating compensation rather than a market purchase.
Following this award, Sultemeier directly holds 3,800 shares of ArcBest common stock. The filing does not show any sales or option exercises, only this routine director-level equity grant that increases his direct ownership stake.
ArcBest Corp director Janice E. Stipp received a stock grant of 1,350 common shares of ArcBest (ARCB). The award was recorded on May 5, 2026 at a stated price of $0.00 per share, indicating it was compensation rather than a market purchase.
After this grant, Stipp directly owns 23,035 shares of ArcBest common stock. The filing does not show any sales or option exercises, only this equity award that modestly increases her direct ownership stake.
MCREYNOLDS JUDY R reported acquisition or exercise transactions in this Form 4 filing.
ArcBest director Judy R. McReynolds reported updated share holdings and a new stock award. A Form 4 shows a grant of 1,350 shares of common stock on May 5, 2026 at a stated price of $0.00 per share, held directly.
The filing also reflects 62,848.14 shares of common stock held indirectly through the McReynolds 2005 Joint Trust. A footnote explains this reported amount was reduced to reflect forfeiture of previously reported time-based restricted stock units in connection with her retirement as Chief Executive Officer effective December 31, 2025.
Hogan Michael P reported acquisition or exercise transactions in this Form 4 filing.
ArcBest Corp. director Michael P. Hogan received a compensation-related grant of 1,350 shares of common stock on May 5, 2026, at no cash cost per share. Following this award, he directly owns 34,014 shares of ArcBest common stock.
Arcbest Corp director Eduardo F. Conrado reported a stock grant of 1,350 common shares. The shares were acquired as a grant or award at a stated price of $0.0000 per share, increasing his direct holdings to 26,225 common shares. He also has 3,600 common shares held indirectly through a trust for which his spouse serves as trustee. The filing reflects compensation-related equity awards rather than open-market buying or selling.
Albrecht Thomas S reported acquisition or exercise transactions in this Form 4 filing.
ARCBEST CORP /DE/ director Thomas S. Albrecht received a grant of 1,350 shares of common stock on May 5, 2026. The award was recorded at a price of $0.00 per share, indicating a share grant rather than a market purchase. Following this transaction, Albrecht directly owns 3,500 shares of ArcBest common stock.
ArcBest Corp. director Salvatore A. Abbate received a stock grant in the company. On May 5, 2026, he acquired 1,350 shares of ArcBest common stock through a grant, award, or similar acquisition at a stated price of $0.00 per share.
After this transaction, Abbate directly holds 7,725 shares of ArcBest common stock. The filing reports no related derivative securities, so this event reflects a straightforward increase in his directly owned common shares.
ARCBEST CORP Schedule 13G reports that FMR LLC beneficially owned 1,290,755.82 shares of common stock, equal to 5.8% of the class as of 03/31/2026. The filing shows sole dispositive power for 1,290,755.82 shares and no shared voting or dispositive power.
ArcBest Corporation reported first-quarter 2026 revenue of $998.8 million, up 3.3% from a year earlier, but posted a net loss of $1.0 million, or $(0.05) per diluted share, versus net income of $3.1 million, or $0.13 per share, in 2025. Adjusted EBITDA was essentially flat at $49.4 million.
The Asset-Based segment grew revenue 1.3% to $655.0 million, with tonnage per day up 6.5% but operating income falling to $17.5 million as higher contractual wages, benefits, and depreciation lifted the operating ratio to 97.3%. Asset-Light revenue rose 6.1% to $377.7 million and improved from a $4.4 million loss to $0.2 million of operating income as shipments per day and per employee increased. Cash and short-term investments declined to $86.4 million after debt repayments, $7.4 million of share repurchases, and $2.7 million in dividends, but the company retained $223.9 million of unused capacity on its $250 million credit facility and $49.7 million under its accounts receivable securitization, and plans 2026 net capital spending of $150 million to $170 million.
Vanguard Capital Management filed a Schedule 13G reporting beneficial ownership of 1,178,027 shares of ArcBest Corp common stock, representing 5.28% of the class. The filer discloses sole dispositive power over 1,178,027 shares and sole voting power over 173,020 shares. The filing lists CUSIP 03937C105 and is signed by Ashley Grim on 04/29/2026.